160 related articles for article (PubMed ID: 34933226)
21. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.
Yoon M; Ahn SH; Kim J; Shin DH; Park SY; Lee SB; Shin KH; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1477-85. PubMed ID: 19879701
[TBL] [Abstract][Full Text] [Related]
22. Estimation of organs doses and radiation-induced secondary cancer risk from scattered photons for conventional radiation therapy of nasopharynx: a Monte Carlo study.
Mesbahi A; Seyednejad F; Gasemi-Jangjoo A
Jpn J Radiol; 2010 Jun; 28(5):398-403. PubMed ID: 20585932
[TBL] [Abstract][Full Text] [Related]
23. Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.
Taddei PJ; Mirkovic D; Fontenot JD; Giebeler A; Zheng Y; Kornguth D; Mohan R; Newhauser WD
Phys Med Biol; 2009 Apr; 54(8):2259-75. PubMed ID: 19305045
[TBL] [Abstract][Full Text] [Related]
24. Comparison of whole-body phantom designs to estimate organ equivalent neutron doses for secondary cancer risk assessment in proton therapy.
Moteabbed M; Geyer A; Drenkhahn R; Bolch WE; Paganetti H
Phys Med Biol; 2012 Jan; 57(2):499-515. PubMed ID: 22217682
[TBL] [Abstract][Full Text] [Related]
25. Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patients.
Athar BS; Bednarz B; Seco J; Hancox C; Paganetti H
Phys Med Biol; 2010 May; 55(10):2879-91. PubMed ID: 20427856
[TBL] [Abstract][Full Text] [Related]
26. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.
Kry SF; Salehpour M; Followill DS; Stovall M; Kuban DA; White RA; Rosen II
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1204-16. PubMed ID: 15990026
[TBL] [Abstract][Full Text] [Related]
27. Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer.
Donovan EM; James H; Bonora M; Yarnold JR; Evans PM
Med Phys; 2012 Oct; 39(10):5814-24. PubMed ID: 23039620
[TBL] [Abstract][Full Text] [Related]
28. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825
[TBL] [Abstract][Full Text] [Related]
29. EVALUATION OF SECONDARY DOSE AND CANCER RISK FOR OUT-OF-FIELD ORGAN IN ESOPHAGEAL CANCER IMRT IN A CHINESE HOSPITAL USING ATOM PHANTOM MEASUREMENTS.
Qi Y; He L; Wang Z; Liu Y; Liu H; Huo W; Xu XG; Chen Z
Radiat Prot Dosimetry; 2017 Dec; 177(4):389-396. PubMed ID: 28472430
[TBL] [Abstract][Full Text] [Related]
30. Measurements of the neutron dose equivalent for various radiation qualities, treatment machines and delivery techniques in radiation therapy.
Hälg RA; Besserer J; Boschung M; Mayer S; Lomax AJ; Schneider U
Phys Med Biol; 2014 May; 59(10):2457-68. PubMed ID: 24778349
[TBL] [Abstract][Full Text] [Related]
31. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis.
Ruben JD; Smith R; Lancaster CM; Haynes M; Jones P; Panettieri V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):645-53. PubMed ID: 25084609
[TBL] [Abstract][Full Text] [Related]
32. Estimation of lifetime attributable risks (LARs) of cancer associated with abdominopelvic radiotherapy treatment planning computed tomography (CT) simulations.
Bagherzadeh S; Jabbari N; Khalkhali HR
Int J Radiat Biol; 2018 May; 94(5):454-461. PubMed ID: 29528791
[TBL] [Abstract][Full Text] [Related]
33. Adjoint Monte Carlo method for prostate external photon beam treatment planning: an application to 3D patient anatomy.
Wang B; Goldstein M; Xu XG; Sahoo N
Phys Med Biol; 2005 Mar; 50(5):923-35. PubMed ID: 15798265
[TBL] [Abstract][Full Text] [Related]
34. Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy.
Athar BS; Paganetti H
Phys Med Biol; 2009 Aug; 54(16):4907-26. PubMed ID: 19641238
[TBL] [Abstract][Full Text] [Related]
35. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.
Reft CS; Runkel-Muller R; Myrianthopoulos L
Med Phys; 2006 Oct; 33(10):3734-42. PubMed ID: 17089839
[TBL] [Abstract][Full Text] [Related]
36. Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy: Organ doses in pediatric brain tumor treatment.
Matsumoto S; Yonai S; Bolch WE
Med Phys; 2019 Dec; 46(12):5824-5832. PubMed ID: 31603561
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy for non-malignant shoulder syndrome: Is there a risk for radiation-induced carcinogenesis?
Mazonakis M; Lyraraki E; Tzedakis A; Damilakis J
Phys Med; 2017 Nov; 43():73-78. PubMed ID: 29195566
[TBL] [Abstract][Full Text] [Related]
38. Monte Carlo evaluation of out-of-field dose in 18 MV pelvic radiotherapy using a simplified female MIRD phantom.
Geraily G; Elmtalab S; Mohammadi N; Alirezaei Z; Martinez-Ovalle SA; Jabbari I; Vega-Carrillo HR; Karimi AH
Biomed Phys Eng Express; 2021 Nov; 8(1):. PubMed ID: 34727526
[TBL] [Abstract][Full Text] [Related]
39. Assessment of individual organ doses in a realistic human phantom from neutron and gamma stimulated spectroscopy of the breast and liver.
Belley MD; Segars WP; Kapadia AJ
Med Phys; 2014 Jun; 41(6):063902. PubMed ID: 24877842
[TBL] [Abstract][Full Text] [Related]
40. Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Phys Med Biol; 2016 Sep; 61(17):6400-12. PubMed ID: 27499236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
